AU2001290103A1 - Methods for diagnosing and treating autosomal dominant optic atrophy - Google Patents

Methods for diagnosing and treating autosomal dominant optic atrophy

Info

Publication number
AU2001290103A1
AU2001290103A1 AU2001290103A AU9010301A AU2001290103A1 AU 2001290103 A1 AU2001290103 A1 AU 2001290103A1 AU 2001290103 A AU2001290103 A AU 2001290103A AU 9010301 A AU9010301 A AU 9010301A AU 2001290103 A1 AU2001290103 A1 AU 2001290103A1
Authority
AU
Australia
Prior art keywords
diagnosing
methods
autosomal dominant
optic atrophy
dominant optic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001290103A
Inventor
Christiana Alexander
Shomi Bhattacharya
Marcela Votruba
Bernd Wissinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNIVERSITY EYE HOSPITAL
University College London
Original Assignee
EYE HOSPITAL, University of
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EYE HOSPITAL, University of, University College London filed Critical EYE HOSPITAL, University of
Publication of AU2001290103A1 publication Critical patent/AU2001290103A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/16—Ophthalmology

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
AU2001290103A 2000-09-26 2001-09-26 Methods for diagnosing and treating autosomal dominant optic atrophy Abandoned AU2001290103A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0023555.6 2000-09-26
GBGB0023555.6A GB0023555D0 (en) 2000-09-26 2000-09-26 Improvements in and relating to treatments for eye disease
PCT/GB2001/004284 WO2002027022A2 (en) 2000-09-26 2001-09-26 Methods for diagnosing and treating autosomal dominant optic atrophy

Publications (1)

Publication Number Publication Date
AU2001290103A1 true AU2001290103A1 (en) 2002-04-08

Family

ID=9900143

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001290103A Abandoned AU2001290103A1 (en) 2000-09-26 2001-09-26 Methods for diagnosing and treating autosomal dominant optic atrophy

Country Status (3)

Country Link
AU (1) AU2001290103A1 (en)
GB (1) GB0023555D0 (en)
WO (1) WO2002027022A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2030021B1 (en) 2006-05-18 2012-11-21 Andreas Reichert Method for diagnosing mitochondrial dysfunction
EP2424495B1 (en) 2009-04-28 2018-01-17 Bioelectron Technology Corporation Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
EP2924127A1 (en) 2014-03-27 2015-09-30 Université Paul Sabatier Toulouse III Method and kit for prognosis of OPA1 gene induced diseases, e.g. Kjers optic atrophy.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2810673B1 (en) * 2000-06-26 2004-10-08 Univ Toulouse HUMAN MITOCHONDRIAL DYNAMINE MSP1 AND ITS USE IN THERAPEUTICS

Also Published As

Publication number Publication date
GB0023555D0 (en) 2000-11-08
WO2002027022A3 (en) 2003-08-28
WO2002027022A2 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AU2627699A (en) Actuators and apparatus
AU5925199A (en) External stress reduction device and method
AU2002332830A1 (en) System and method for diagnosing and/or reducing tinnitus
AU4322999A (en) Methods and compositions for diagnosing tauopathies
AU2001284865A1 (en) Methods for diagnosing and treating dysautonomia and other dysautonomic conditions
AU5294100A (en) Method and compositions for treating the inflammatory response
AU2001245977A1 (en) Method and composition for preventing or reducing the symptoms of menopause
AU1834000A (en) Ophthalmic compositions comprising pheniramine and povidone
AU2001279850A1 (en) Method and arrangement for studsystem
AU1972600A (en) Viscoelastic bleaching and disinfecting agents
AU2001289123A1 (en) Compounds and methods for diagnosing and treating amyloid-related conditions
AU2002234660A1 (en) Method and arrangement for interference attenuation
AU2750000A (en) Cassette adapter and method
AU2001278135A1 (en) Method of identifying immunosuppressive agents
AU2001290103A1 (en) Methods for diagnosing and treating autosomal dominant optic atrophy
AU2001261513A1 (en) Composition and method for increasing testosterone levels
AU5243899A (en) Methods and compositions for using moclobemide
AU7308300A (en) Agents for reducing cholesterol-uptake and liquid-uptake
AU2002217915A1 (en) Compositions and methods for diagnosing or treating psoriasis
EP1031954A3 (en) Measuring arrangement and method
AU2002364722A1 (en) Methods and compositions for diagnosing and treating hypotrichosis simplex
AU4218500A (en) Methods and apparatus for measuring hydroperoxides
AU7572200A (en) Multipath optical coupler and associated method
AU2664900A (en) Wagering device and method